pipette
ENEnglish

A network of syringe-injectable bioelectronics for closed-loop therapeutic rescue

J. Jackson, W. Sohn, L. Testu, R. Ghanim, M. Aamir, M. Angia, A. Cig, S. Healy, Z. Lee, J. Y. Chin, J. Z. Ding, J. Park, J. Maisha, Y. J. Lee, A. Abramson

PreprintAfirmaciones fuertes, leer con cuidadoDice ser un gran avanceUso en el mundo real

En palabras de los autores

An on-body network of sensors and drug delivery implants could transform treatments for rapid-onset morbidities that require bystander intervention. During opioid overdoses, for example, lone and incapacitated victims often cannot self-administer life-saving naloxone in the minutes before respiratory collapse. However, the bulkiness of existing closed-loop systems threatens patient acceptance. Here, we present the Rapid Emergency Subcutaneous platform (RES-Q), a network of wearable sensors and syringe-implantable autoinjectors for closed-loop therapy. RES-Q implants are similar in size to FDA-approved drug rod implants and fit inside 6-gauge needles to facilitate outpatient administration. Informed by implant fibrosis fracture mechanics, RES-Q employs miniature jet injectors that deliver 0.4 mg human-relevant doses of naloxone through fibrotic encapsulation for rapid uptake. RES-Q implants communicate with wearable sensors through tissue conductivity, resulting in 25 nA standby current draws that ensure long-term functionality. In swine, we sequentially trigger multiple implants using ionic tissue communication. In rats, RES-Q detects fentanyl overdoses using wearable photoplethysmography sensors and performs autonomous, dose-titratable rescue in < 6 minutes.

Resultado principalEl resumen no menciona limitaciones.

Apareció: viernes, 13 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.10.765435